Oncology News

A higher selenium level before cancer onset was associated with a decreased risk for hepatocellular carcinoma in a European population, according to recent findings published in The American Journal of Clinical Nutrition.

According to a recent study, patients with liver tumors achieved greater depth of response when they received chemotherapy plus SIR-Spheres Y-90 resin microspheres compared with chemotherapy alone.

The Extended Toronto Criteria provided a 10-year survival rate similar to the currently used Milan Criteria, according to recent findings published in Hepatology. Both criteria are used to determine whether patients with hepatocellular carcinoma should receive a liver transplant by excluding those deemed to have a poor chance of survival. The Milan Criteria uses tumor size and number whereas the Extended Toronto Criteria uses tumor differentiation, cancer-related symptoms, confinement to the liver and venous or biliary tumor thrombus for patients who were previously excluded from transplant by the Milan criteria.

Adults who consumed more than two sugar-sweetened beverages each day appeared to experience an increased risk for biliary tract cancer, according to the result of a Swedish national prospective cohort study.

ARQ 087, a multi-kinase inhibitor designed to inhibit fibroblast growth factor receptor, displayed a favorable safety profile when administered as monotherapy to patients with intrahepatic cholangiocarcinoma, according to data presented at the European Society of Medical Oncology 18th World Congress on Gastrointestinal Cancer.

Patients with hepatitis B virus infection treated with Baraclude had an unexpected lower incidence of hepatocellular carcinoma over time, although the risk for hepatocellular carcinoma in this patient population still persisted, according to the results of a retrospective study.

Coffee no longer should be classified as carcinogenic to humans, according to a working group from WHO’s International Agency for Research on Cancer.

Taking Decadron combined with Emend prior to drug eluting bead transarterial chemoembolization helped prevent postembolization syndrome posttreatment in patients with hepatocellular carcinoma, according to findings presented at the World Conference on Interventional Oncology.

CHICAGO — Hispanic and black adolescents and young adults have an increased risk for mortality from several cancers — including hepatocellular carcinoma — compared with whites, according to results from a population-based study presented at the ASCO Annual Meeting.

The Asia-Pacific Hepatocellular Carcinoma Trials Group, National Cancer Centre Singapore, Singapore Clinical Research Institute and Sirtex Medical Limited announced that the AHCC protocol 06 SIRveNIB randomized controlled study of SIR-Spheres Y-90 microspheres vs. sorafenib for the treatment of hepatocellular carcinoma has reached target enrollment of at least 360 patients.